STERIS plc (STE)

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Ireland Revenue	114.71M	107.32M	82.70M
Ireland Revenue Growth	6.88%	29.78%	11.31%
United States Revenue	4.27B	4.01B	3.75B
United States Revenue Growth	6.46%	6.83%	15.27%
Other Locations Revenue	1.45B	1.34B	1.30B
Other Locations Revenue Growth	7.60%	3.07%	8.03%
Revenue (Other)	-1.50B	-	-
Revenue (Total)	4.33B	5.46B	5.14B
Revenue (Total) Growth	-20.65%	6.24%	13.28%

Revenue

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Healthcare Revenue	4.13B	3.88B	3.61B
Healthcare Revenue Growth	6.47%	7.35%	17.11%
Applied Sterilization Technologies Revenue	1.12B	1.04B	953.98M
Applied Sterilization Technologies Revenue Growth	8.15%	8.87%	4.32%
Life Sciences Revenue	575.47M	542.27M	571.70M
Life Sciences Revenue Growth	6.12%	-5.15%	6.52%
Revenue (Other)	-1.50B	-	-
Revenue (Total)	4.33B	5.46B	5.14B
Revenue (Total) Growth	-20.65%	6.24%	13.28%

EBIT

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Healthcare Operating Income	1.03B	971.52M	871.36M
Healthcare Operating Income Growth	6.31%	11.49%	23.42%
Applied Sterilization Technologies Operating Income	515.70M	465.58M	439.74M
Applied Sterilization Technologies Operating Income Growth	10.77%	5.87%	2.50%
Life Sciences Operating Income	245.42M	229.44M	221.35M
Life Sciences Operating Income Growth	6.97%	3.66%	5.29%
Operating Income (Total)	727.95M	866.64M	836.12M
Operating Income (Total) Growth	-16.00%	3.65%	5.69%

Key Performance Indicators

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Constant Currency Organic Revenue Growth	6.20%	8.90%

Updated Dec 31, 2025. Data Source: Fiscal.ai.